The Global Allergy Diagnostics Market size is expected to reach $11.4 billion by 2028, rising at a market growth of 13.3% CAGR during the forecast period.
A reaction or hypersensitivity brought on by the immune system is an allergy. An allergen is anything that triggers allergic reactions; examples include pollen, pet dander, dust mite secretion, and others. Skin allergies, food allergies, insect allergies, mould allergies, and medication allergies are a few of the most prevalent allergens. The type of allergy and the most appropriate course of treatment can also be determined by an allergy diagnostic test.
Techniques for diagnosing allergies include skin prick tests, patch tests, intradermal tests, and blood tests. As pollution levels rise, the market for allergy diagnostics is anticipated to expand. The main risk factors for chronic respiratory illnesses include occupational exposure, exposure to allergens, and exposure to both indoor and outdoor air pollution.
Due to their greater exposure to environmental pollutants, urban individuals are more susceptible than rural ones to suffering allergy disorders. The market for allergy diagnostics is expected to grow due to the increase in food allergies. The allergy cases are more common in urban areas instead of rural areas. The degree of cleanliness and potential for infectious diseases is one of the most noticeable differences between these places.
Early exposure to viral, bacterial, and parasite infections as well as exposure to a number of common human body micro-organisms are predicted to have an impact on immune system development. Climate change, air pollution, as well as the complexity of materials and cosmetic products have all contributed to a rise in the prevalence of sensitive skin and its susceptibility to irritation. These elements are anticipated to fuel the market for allergy diagnostics in the near future.
Due to the COVID-19 outbreak, there was a little reduction in the market for allergy diagnostic. Given that suffering patients are well-instructed about avoiding probable environmental triggers and treating acute occurrences, also based on written action plans, diagnostic tests were postponed in the majority of allergic disorders. However, after the pandemic was under control, the diagnostic processes were restarted. To determine the impact of COVID-19 on allergy diagnostic testing services, several researches have been done.
The main risk factors for developing chronic respiratory disorders include occupational exposure, allergen exposure, and exposure to indoor and outdoor air pollution. Due to the greater exposure to environmental toxins in cities, the prevalence of allergy illnesses is higher among urban residents than rural residents (as a result of vehicular pollution and industrial activities). Although this is a worldwide phenomenon, its impacts are more severe in the metropolitan regions of low-income nations, where more than 80% of people live in locations where air quality levels exceed WHO safety guidelines.
There are currently just a few mHealth tools for diagnosing allergic rhinitis (AR) that have been published in peer-reviewed publications, which limits the use of mHealth for the diagnosis of rhinitis. A new breed of point-of-care devices is produced by recent advancements in wireless communication, integrated biosensors, and power harvesting techniques. However, AR is a very widespread illness all over the world. Peak nasal inspiratory flow meters and intranasal biosensors are only two examples of diagnostic tools that can be connected to smartphones.
Market competitors regularly update a number of allergy diagnostic tools, including luminometers, scanners, blot analyzers, ELISA analyzers, and immunoassay analyzers. These instruments cost more because they come with cutting-edge features and functions (the cost of each instrument varies on the basis of its flexibility, accuracy, and TAT). Due to their substantial capital expenditures and ability to purchase high-volume systems, large hospitals and diagnostic laboratories hold a higher portion of the market.
Based on end-user, the allergy diagnostics market is classified into diagnostics laboratories, hospital-based laboratories, academic research institutes and others. The hospital-based laboratories segment registered a significant revenue share in the allergy diagnostics market in 2021. There are a large number of hospitals operated by private as well as public authorities. The government is largely supporting this segment and thus is increasing the healthcare spending in hospitals-based laboratories. These elements would further support the allergy diagnostics market growth in the near future years.
By allergen, the allergy diagnostics market is divided into inhaled allergens, food allergens, drug allergens, and other allergens. The inhaled segment held the largest revenue share in the allergy diagnostics market in 2021. Rising pollen and environmental pollution levels, along with other factors such as dust, mould, and fungus, may be responsible for the allergy diagnostics market rise in the inhaled allergens segment. These elements could all increase consumer demand for inhaled allergens and thus would hasten market growth over the forecast period.
Based on test type, the allergy diagnostics market is segmented into in vitro and in vivo. The in vitro segment acquired a substantial revenue share in the allergy diagnostics market in 2021. The in vitro test is used to determine the presence of immunoglobulin E specific to allergens (IgE). An in-vitro method for identifying allergen-specific antibodies of a novel immunoglobulin class, tentatively referred to as IgND, is the radio allergosorbent test. The advantages of in vitro testing include its compatibility with any skin condition, lack of systemic reaction risk, lack of steroid or anti-histaminic effects, and absence of compatibility issues.
On the basis of product & services, the allergy diagnostics market is fragmented into consumables, instruments, and services. In 2021, the consumable segment witnessed the highest revenue share in the allergy diagnostics market. The increased number of allergies that require rapid detection is one of the factors pushing market expansion. Major market players across the globe are also collaborating strategically to give consumers improved allergy diagnoses. These factors and strategic alliances by significant companies may contribute to the segments throughout the projection period.
| Report Attribute | Details |
|---|---|
| Market size value in 2021 | USD 4.8 Billion |
| Market size forecast in 2028 | USD 11.4 Billion |
| Base Year | 2021 |
| Historical Period | 2018 to 2020 |
| Forecast Period | 2022 to 2028 |
| Revenue Growth Rate | CAGR of 13.3% from 2022 to 2028 |
| Number of Pages | 244 |
| Number of Tables | 450 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling |
| Segments covered | Allergen, Test Type, Product & Services, End-user, Region |
| Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
| Growth Drivers |
|
| Restraints |
|
Region wise, the allergy diagnostics market is analyzed across the North America, Europe, Asia Pacific and LAMEA. In 2021, the North America region led the allergy diagnostics market with the maximum revenue share. The growth of the regional market is primarily driven by the rising number of allergy sufferers, improved healthcare infrastructure, as well as cutting-edge diagnostic technologies. As the number of fatalities linked to pharmaceutical allergies rises, so will the demand for rapid and reliable allergy diagnosis.
Free Valuable Insights: Global Allergy Diagnostics Market size to reach USD 11.4 Billion by 2028
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation, Hitachi chemical Diagnostic Inc., Hycor Biomedical Inc., Lincoln Diagnostics Inc., Omega Diagnostic Llc, Siemens Healthcare Diagnostics, Inc., Thermo Fisher Scientific Inc., Neogen Corporation, Eurofins Scientific Group, and ACON Laboratories, Inc.
By End-user
By Allergen
By Test Type
By Product & Services
By Geography
The global Allergy Diagnostics Market size is expected to reach $11.4 billion by 2028.
Increasing levels of environmental pollution are driving the market in coming years, however, Instruments for diagnosing allergies come at a premium price restraints the growth of the market.
Danaher Corporation, Hitachi chemical Diagnostic Inc., Hycor Biomedical Inc., Lincoln Diagnostics Inc., Omega Diagnostic Llc, Siemens Healthcare Diagnostics, Inc., Thermo Fisher Scientific Inc., Neogen Corporation, Eurofins Scientific Group, and ACON Laboratories, Inc.
The expected CAGR of the Allergy Diagnostics Market is 13.3% from 2022 to 2028.
The Diagnostic Laboratories market is generating high revenue in the Global Allergy Diagnostics Market by End-user in 2021; thereby, achieving a market value of $5.2 billion by 2028.
The North America market region shows high market share in the Global Allergy Diagnostics Market by Region in 2021; thereby, achieving a market value of $4.3 billion by 2028.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 